SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-028856
Filing Date
2023-08-10
Accepted
2023-08-10 16:13:10
Documents
53
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nltx-20230630.htm   iXBRL 10-Q 1127999
2 EX-31.1 exhibit3112023q2.htm EX-31.1 9593
3 EX-31.2 exhibit3122023q2.htm EX-31.2 9574
4 EX-32.1 exhibit3212023q2.htm EX-32.1 7146
  Complete submission text file 0001628280-23-028856.txt   4640425

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nltx-20230630.xsd EX-101.SCH 24724
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nltx-20230630_cal.xml EX-101.CAL 39000
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nltx-20230630_def.xml EX-101.DEF 140932
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nltx-20230630_lab.xml EX-101.LAB 414112
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nltx-20230630_pre.xml EX-101.PRE 266624
47 EXTRACTED XBRL INSTANCE DOCUMENT nltx-20230630_htm.xml XML 497660
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 231159523
SIC: 2834 Pharmaceutical Preparations